Acute liver injury in a non-alcoholic fatty liver disease patient with chloroform exposure: a case report

被引:0
|
作者
Yosuke Suehiro
Takuro Uchida
Masataka Tsuge
Eisuke Murakami
Daiki Miki
Tomokazu Kawaoka
Michio Imamura
Hiroshi Aikata
Koji Arihiro
Shiro Oka
机构
[1] Hiroshima University,Department of Gastroenterology, Graduate School of Biomedical and Health Sciences
[2] Hiroshima University,Natural Science Center for Basic Research and Development
[3] Hiroshima University Hospital,Department of Pathology
来源
关键词
Acute liver injury; Non-alcoholic steatohepatitis; Chloroform exposure;
D O I
暂无
中图分类号
学科分类号
摘要
We report a rare case of acute liver injury by daily exposure to small amounts of chloroform in non-alcoholic fatty liver disease (NAFLD) patient. The patient had been followed up in our hospital every 3 months. Although his alanine aminotransferase (ALT) levels were steady around 30 ~ 60 U/L until August 2014, ALT level was spontaneously increased to more than 1,000 U/L at the follow-up point in late August 2014. As he was diagnosed as acute liver injury by chloroform exposure, we withdrew him from the exposure of chloroform and treated him with 600 mg/day of ursodeoxycholic acid. Afterwards, his ALT level rapidly improved and normalized within 1 month. To verify the influences of chloroform exposure, we measured plasma chloroform levels by gas chromatography. Although plasma chloroform concentration was 7.1 ng/ml (normal range: < 0.2 ng/ml) at the time of liver injury, the concentration had decreased to 0.7 ng/ml by 1 month later. Despite the fact that he had put on a face mask to protect from aspiration of chloroform, liver injury still occurred in the present case. Chloroform has a high solubility for lipids and accumulation of lipids in the liver might become a risk factor for liver injury by chloroform.
引用
收藏
页码:250 / 253
页数:3
相关论文
共 50 条
  • [41] Acute on chronic liver failure in non-alcoholic fatty liver and alcohol associated liver disease
    Singal, Ashwani K.
    Kamath, Patrick S.
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [42] STATINS AND LIVER INJURY IN MORBIDLY OBESE SUBJECTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Aggarwal, Vipul
    Palmer, Clovis S.
    Yan, Kenneth K.
    Lloyd, Andrew R.
    Zekry, Amany
    HEPATOLOGY, 2009, 50 (04) : 789A - 789A
  • [43] Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease
    Lemoine, Maud
    Ratziu, Vlad
    Kim, Minji
    Maachi, Mustapha
    Wendum, Dominique
    Paye, Francois
    Bastard, Jean Philippe
    Poupon, Raoul
    Housset, Chantal
    Capeau, Jacqueline
    Serfaty, Lawrence
    LIVER INTERNATIONAL, 2009, 29 (09) : 1431 - 1438
  • [44] Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
    Eslami, Layli
    Merat, Shahin
    Malekzadeh, Reza
    Nasseri-Moghaddam, Siavosh
    Aramin, Hermineh
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (12):
  • [45] Hepatic exposure of metformin in patients with non-alcoholic fatty liver disease
    Sundelin, Elias Immanuel Ordell
    Gormsen, Lars Christian
    Heeboll, Sara
    Vendelbo, Mikkel Holm
    Jakobsen, Steen
    Munk, Ole Lajord
    Feddersen, Soren
    Brosen, Kim
    Hamilton-Dutoit, Stephen Jacques
    Pedersen, Steen Bonlokke
    Gronbaek, Henning
    Jessen, Niels
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (08) : 1761 - 1770
  • [46] The epidemiology of non-alcoholic fatty liver disease
    Bellentani, Stefano
    LIVER INTERNATIONAL, 2017, 37 : 81 - 84
  • [47] Non-alcoholic fatty liver disease in children
    Chaturvedi, Kanupriya
    Vohra, Pankaj
    INDIAN PEDIATRICS, 2012, 49 (09) : 757 - 758
  • [48] Pathology of non-alcoholic fatty liver disease
    Bedossa, Pierre
    LIVER INTERNATIONAL, 2017, 37 : 85 - 89
  • [49] Non-alcoholic fatty liver disease and diabetes
    Reyes-Garcia, Rebeca
    Rozas-Moreno, Pedro
    Julio Llamoza-Torres, Camilo
    Mezquita-Raya, Pedro
    MEDICINA CLINICA, 2017, 148 (01): : 33 - 38
  • [50] Hyperuricemia in non-alcoholic fatty liver disease
    Dogru, T.
    Genc, H.
    Tapan, S.
    Bagci, S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 34 (08) : 1042 - 1043